Search Results

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    First-line atezolizumab plus nab-paclitaxel for unresectable, locally advanced, or metastatic triple-negative breast cancer: IMpassion130 final overall survival analysis by Emens, Leisha Ann (Author) , Adams, S. (Author) , Barrios, C. H. (Author) , Diéras, V. (Author) , Iwata, H. (Author) , Loi, S. (Author) , Rugo, H. S. (Author) , Schneeweiss, Andreas (Author) , Winer, E. P. (Author) , Patel, S. (Author) , Henschel, V. (Author) , Swat, A. (Author) , Kaul, M. (Author) , Molinero, L. (Author) , Chui, S. Y. (Author) , Schmid, P. (Author) ,


    Get full text
    Article (Journal) Online Resource
  2. 2

    Patient-reported outcomes from the phase III IMpassion130 trial of atezolizumab plus nab-paclitaxel in metastatic triple-negative breast cancer by Adams, Sylvia (Author) , Dieras, V. (Author) , Barrios, C. H. (Author) , Winer, E. P. (Author) , Schneeweiss, Andreas (Author) , Iwata, H. (Author) , Loi, S. (Author) , Patel, S. (Author) , Henschel, V. (Author) , Chui, S. Y. (Author) , Rugo, H. S. (Author) , Emens, L. A. (Author) , Schmid, P. (Author) ,


    Get full text
    Article (Journal) Online Resource
  3. 3

    Nab-paclitaxel plus carboplatin or gemcitabine versus gemcitabine plus carboplatin as first-line treatment of patients with triple-negative metastatic breast cancer: results from t... by Yardley, Denise (Author) , Coleman, R. (Author) , Conte, P. (Author) , Cortes, J. (Author) , Brufsky, A. (Author) , Shtivelband, M. (Author) , Young, R. (Author) , Bengala, C. (Author) , Ali, H. (Author) , Eakel, J. (Author) , Schneeweiss, Andreas (Author) , de la Cruz-Merino, L. (Author) , Wilks, S. (Author) , O’Shaughnessy, J. (Author) , Glück, S. (Author) , Li, H. (Author) , Miller, J. (Author) , Barton, D. (Author) , Harbeck, N. (Author) ,


    Get full text
    Article (Journal) Online Resource
  4. 4

    A randomized phase 2 study comparing EC or CMF versus nab-paclitaxel plus capecitabine as adjuvant chemotherapy for nonfrail elderly patients with moderate to high-risk early breas... by Minckwitz, Gunter von (Author) , Conrad, Bettina (Author) , Reimer, Toralf (Author) , Decker, Thomas (Author) , Eidtmann, Holger (Author) , Eiermann, Wolfgang (Author) , Hackmann, John (Author) , Möbus, Volker (Author) , Marmé, Frederik (Author) , Potenberg, Jochem (Author) , Stickeler, Elmar (Author) , Simon, Eike (Author) , Thomssen, Christoph (Author) , Huober, Jens (Author) , Denkert, Carsten (Author) , Alfer, Joachim (Author) , Jackisch, Christian (Author) , Nekljudova, Valentina (Author) , Burchardi, Nicole (Author) , Loibl, Sibylle (Author) ,


    Get full text
    Article (Journal) Online Resource
  5. 5

    Efficacy of nab-paclitaxel does not seem to be associated with SPARC expression in metastatic breast cancer by Schneeweiss, Andreas (Author) , Seitz, Julia (Author) , Smetanay, Katharina (Author) , Schütz, Florian (Author) , Jäger, Dirk (Author) , Zorn, Markus (Author) , Sinn, Peter (Author) , Marmé, Frederik (Author) ,


    Get full text
    Article (Journal) Online Resource
  6. 6

    Nab-paclitaxel monotherapy as a treatment of patients with metastatic breast cancer in routine clinical practice by Aigner, Julia (Author) , Marmé, Frederik (Author) , Smetanay, Katharina (Author) , Schütz, Florian (Author) , Jäger, Dirk (Author) , Schneeweiss, Andreas (Author) ,


    Get full text
    Article (Journal) Online Resource